Jazz Pharmaceuticals PLC (JAZZ) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Biotechnology industry.
Over the past 4 years, Jazz Pharmaceuticals PLC has achieved a revenue compound annual growth rate (CAGR) of 57.2%, while earnings have grown at 43.1% CAGR.
Historical revenue and profitability trends for Jazz Pharmaceuticals PLC
The chart above illustrates Jazz Pharmaceuticals PLC's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Jazz Pharmaceuticals PLC's business.
How efficiently Jazz Pharmaceuticals PLC converts revenue into profit
Profit margins reveal how much of each dollar of revenue Jazz Pharmaceuticals PLC retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Jazz Pharmaceuticals PLC to continue growing earnings in the coming year. The consensus analyst rating is 4.4444 based on 18 analysts.
Based on our comprehensive analysis, Jazz Pharmaceuticals PLC (JAZZ) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Jazz Pharmaceuticals PLC's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Jazz Pharmaceuticals PLC stacks up against similar companies
Explore growth analysis for top stocks
Related: JAZZ Valuation, JAZZ Dividend, JAZZ Financial Health
Compare: JAZZ vs AAPL, JAZZ vs MSFT, JAZZ vs GOOGL